Datasets:
registry_id stringlengths 17 17 | year int64 2.01k 2.02k | age int64 0 95 | age_group stringclasses 8
values | sex stringclasses 2
values | cancer_type stringclasses 22
values | morphology stringclasses 8
values | grade stringclasses 5
values | basis_of_diagnosis stringclasses 5
values | behavior stringclasses 3
values | residence stringclasses 3
values | treatment_status stringclasses 8
values | vital_status stringclasses 3
values | survival_months float64 0 60 | scenario stringclasses 3
values |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
KE-NRB-2010-00001 | 2,010 | 45 | 45-54 | Male | Oesophagus | Lymphoma | Moderately differentiated (Grade II) | Microscopy (histology/cytology) | Malignant | Urban | No treatment | Alive | 34.1 | high_burden |
KE-NRB-2018-00002 | 2,018 | 24 | 15-24 | Female | Other | Leukemia | Poorly differentiated (Grade III) | Microscopy (histology/cytology) | Malignant | Peri-urban | Surgery only | Alive | 25.8 | high_burden |
KE-NRB-2013-00003 | 2,013 | 42 | 35-44 | Female | Other | Adenocarcinoma | Well differentiated (Grade I) | Imaging + clinical | Malignant | Urban | Surgery only | Lost to follow-up | 60 | high_burden |
KE-NRB-2015-00004 | 2,015 | 71 | 65-74 | Male | Colorectum | Sarcoma | Unknown | Microscopy (histology/cytology) | Benign/uncertain | Peri-urban | null | Dead | 19 | high_burden |
KE-NRB-2012-00005 | 2,012 | 54 | 45-54 | Female | Thyroid | Squamous cell carcinoma | Poorly differentiated (Grade III) | Clinical only | Malignant | Urban | Chemotherapy only | Alive | 60 | high_burden |
KE-NRB-2014-00006 | 2,014 | 81 | 75+ | Female | Breast | Sarcoma | Moderately differentiated (Grade II) | Microscopy (histology/cytology) | Malignant | Urban | Chemotherapy only | Alive | 38.3 | high_burden |
KE-NRB-2012-00007 | 2,012 | 17 | 15-24 | Male | Bladder | Lymphoma | Poorly differentiated (Grade III) | Microscopy (histology/cytology) | Malignant | Urban | No treatment | Alive | 0.8 | high_burden |
KE-NRB-2017-00008 | 2,017 | 52 | 45-54 | Female | Other | Adenocarcinoma | Moderately differentiated (Grade II) | Imaging + clinical | Malignant | Peri-urban | Chemo + Radiotherapy | Alive | 54.2 | high_burden |
KE-NRB-2016-00009 | 2,016 | 36 | 35-44 | Male | Other | Adenocarcinoma | Poorly differentiated (Grade III) | Microscopy (histology/cytology) | Malignant | Urban | Surgery only | Alive | 3.6 | high_burden |
KE-NRB-2015-00010 | 2,015 | 52 | 45-54 | Female | Corpus uteri | Lymphoma | Undifferentiated (Grade IV) | Microscopy (histology/cytology) | Malignant | Urban | Surgery only | Alive | 11.1 | high_burden |
KE-NRB-2012-00011 | 2,012 | 67 | 65-74 | Female | Other | Leukemia | Moderately differentiated (Grade II) | Microscopy (histology/cytology) | Malignant | Urban | Surgery only | Dead | 38.1 | high_burden |
KE-NRB-2016-00012 | 2,016 | 43 | 35-44 | Female | Other | Squamous cell carcinoma | Moderately differentiated (Grade II) | Death certificate only | Malignant | Peri-urban | Surgery only | Dead | 34.1 | high_burden |
KE-NRB-2013-00013 | 2,013 | 78 | 75+ | Female | Breast | Squamous cell carcinoma | Well differentiated (Grade I) | Microscopy (histology/cytology) | Malignant | Urban | Chemo + Radiotherapy | Dead | 10.4 | high_burden |
KE-NRB-2009-00014 | 2,009 | 48 | 45-54 | Male | Other | Adenocarcinoma | Poorly differentiated (Grade III) | Microscopy (histology/cytology) | Malignant | Urban | Chemo + Radiotherapy | Alive | 60 | high_burden |
KE-NRB-2017-00015 | 2,017 | 61 | 55-64 | Female | Other | Squamous cell carcinoma | Well differentiated (Grade I) | Microscopy (histology/cytology) | Malignant | Urban | Palliative care only | Alive | 22.4 | high_burden |
KE-NRB-2016-00016 | 2,016 | 67 | 65-74 | Female | Cervix uteri | Adenocarcinoma | Moderately differentiated (Grade II) | Microscopy (histology/cytology) | Malignant | Urban | No treatment | Dead | 24.1 | high_burden |
KE-NRB-2013-00017 | 2,013 | 47 | 45-54 | Female | Other | Lymphoma | Poorly differentiated (Grade III) | Microscopy (histology/cytology) | Malignant | Urban | Surgery + Radiotherapy | Alive | 57 | high_burden |
KE-NRB-2017-00018 | 2,017 | 56 | 55-64 | Male | Kaposi sarcoma | Adenocarcinoma | Poorly differentiated (Grade III) | Microscopy (histology/cytology) | Malignant | Urban | Surgery only | Dead | 6.6 | high_burden |
KE-NRB-2017-00019 | 2,017 | 44 | 35-44 | Female | Cervix uteri | Non-keratinizing carcinoma | Well differentiated (Grade I) | Microscopy (histology/cytology) | Malignant | Urban | Surgery only | Alive | 16 | high_burden |
KE-NRB-2010-00020 | 2,010 | 41 | 35-44 | Female | Other | Squamous cell carcinoma | Moderately differentiated (Grade II) | Microscopy (histology/cytology) | Malignant | Urban | Surgery only | Alive | 13.8 | high_burden |
KE-NRB-2015-00021 | 2,015 | 29 | 25-34 | Female | Cervix uteri | Adenocarcinoma | Well differentiated (Grade I) | Imaging + clinical | Malignant | Peri-urban | Chemotherapy only | Alive | 60 | high_burden |
KE-NRB-2015-00022 | 2,015 | 35 | 35-44 | Female | Breast | Non-keratinizing carcinoma | Undifferentiated (Grade IV) | Microscopy (histology/cytology) | Malignant | Peri-urban | Surgery only | Alive | 60 | high_burden |
KE-NRB-2013-00023 | 2,013 | 50 | 45-54 | Female | Thyroid | Adenocarcinoma | Undifferentiated (Grade IV) | Other | Malignant | Urban | Surgery + Radiotherapy | Dead | 9.2 | high_burden |
KE-NRB-2015-00024 | 2,015 | 57 | 55-64 | Male | Oesophagus | Adenocarcinoma | Moderately differentiated (Grade II) | Microscopy (histology/cytology) | Malignant | Urban | Chemo + Radiotherapy | Alive | 3.6 | high_burden |
KE-NRB-2016-00025 | 2,016 | 46 | 45-54 | Male | Oesophagus | Squamous cell carcinoma | Undifferentiated (Grade IV) | Microscopy (histology/cytology) | Malignant | Urban | Chemotherapy only | Dead | 15.8 | high_burden |
KE-NRB-2012-00026 | 2,012 | 56 | 55-64 | Female | Ovary | Other specified | Poorly differentiated (Grade III) | Microscopy (histology/cytology) | Malignant | Rural | Radiotherapy only | Alive | 60 | high_burden |
KE-NRB-2012-00027 | 2,012 | 74 | 65-74 | Female | Breast | Non-keratinizing carcinoma | Moderately differentiated (Grade II) | Microscopy (histology/cytology) | Malignant | Urban | Surgery only | Alive | 60 | high_burden |
KE-NRB-2014-00028 | 2,014 | 35 | 35-44 | Male | Bladder | Non-keratinizing carcinoma | Poorly differentiated (Grade III) | Microscopy (histology/cytology) | Malignant | Urban | Chemotherapy only | Alive | 60 | high_burden |
KE-NRB-2009-00029 | 2,009 | 39 | 35-44 | Female | Other | Other specified | Moderately differentiated (Grade II) | Microscopy (histology/cytology) | Benign/uncertain | Urban | null | Dead | 23.3 | high_burden |
KE-NRB-2014-00030 | 2,014 | 39 | 35-44 | Female | Breast | Squamous cell carcinoma | Undifferentiated (Grade IV) | Microscopy (histology/cytology) | Malignant | Urban | Surgery only | Alive | 38 | high_burden |
KE-NRB-2014-00031 | 2,014 | 35 | 35-44 | Female | Other | Non-keratinizing carcinoma | Poorly differentiated (Grade III) | Imaging + clinical | Malignant | Urban | Surgery + Chemotherapy | Alive | 14.5 | high_burden |
KE-NRB-2018-00032 | 2,018 | 90 | 75+ | Male | Other | Adenocarcinoma | Moderately differentiated (Grade II) | Imaging + clinical | Malignant | Urban | Chemotherapy only | Dead | 6 | high_burden |
KE-NRB-2014-00033 | 2,014 | 52 | 45-54 | Female | Ovary | Adenocarcinoma | Poorly differentiated (Grade III) | Microscopy (histology/cytology) | Malignant | Rural | Surgery only | Lost to follow-up | 32.4 | high_burden |
KE-NRB-2012-00034 | 2,012 | 74 | 65-74 | Female | Other | Sarcoma | Moderately differentiated (Grade II) | Clinical only | Malignant | Urban | Surgery + Chemotherapy | Alive | 35.1 | high_burden |
KE-NRB-2015-00035 | 2,015 | 29 | 25-34 | Male | Pancreas | Squamous cell carcinoma | Poorly differentiated (Grade III) | Microscopy (histology/cytology) | Malignant | Urban | Chemotherapy only | Dead | 7 | high_burden |
KE-NRB-2016-00036 | 2,016 | 54 | 45-54 | Female | Other | Adenocarcinoma | Well differentiated (Grade I) | Microscopy (histology/cytology) | Malignant | Urban | Surgery + Radiotherapy | Alive | 25.3 | high_burden |
KE-NRB-2011-00037 | 2,011 | 73 | 65-74 | Female | Breast | Squamous cell carcinoma | Poorly differentiated (Grade III) | Microscopy (histology/cytology) | Malignant | Urban | No treatment | Alive | 17.6 | high_burden |
KE-NRB-2017-00038 | 2,017 | 61 | 55-64 | Female | Cervix uteri | Squamous cell carcinoma | Poorly differentiated (Grade III) | Clinical only | Malignant | Urban | Surgery only | Alive | 19 | high_burden |
KE-NRB-2014-00039 | 2,014 | 67 | 65-74 | Male | Colorectum | Lymphoma | Undifferentiated (Grade IV) | Microscopy (histology/cytology) | Malignant | Urban | No treatment | Lost to follow-up | 47.9 | high_burden |
KE-NRB-2009-00040 | 2,009 | 2 | 0-14 | Female | Breast | Lymphoma | Unknown | Clinical only | Malignant | Rural | Surgery + Radiotherapy | Alive | 1.1 | high_burden |
KE-NRB-2011-00041 | 2,011 | 67 | 65-74 | Male | Other | Unspecified | Poorly differentiated (Grade III) | Microscopy (histology/cytology) | Malignant | Urban | Surgery + Chemotherapy | Alive | 46.8 | high_burden |
KE-NRB-2013-00042 | 2,013 | 23 | 15-24 | Male | Other | Non-keratinizing carcinoma | Moderately differentiated (Grade II) | Clinical only | Malignant | Urban | Palliative care only | Alive | 60 | high_burden |
KE-NRB-2018-00043 | 2,018 | 56 | 55-64 | Male | Prostate | Squamous cell carcinoma | Undifferentiated (Grade IV) | Microscopy (histology/cytology) | Malignant | Urban | Surgery only | Alive | 40 | high_burden |
KE-NRB-2017-00044 | 2,017 | 39 | 35-44 | Male | Prostate | Lymphoma | Poorly differentiated (Grade III) | Microscopy (histology/cytology) | Malignant | Urban | Chemo + Radiotherapy | Alive | 8.2 | high_burden |
KE-NRB-2018-00045 | 2,018 | 46 | 45-54 | Female | Cervix uteri | Non-keratinizing carcinoma | Moderately differentiated (Grade II) | Microscopy (histology/cytology) | Malignant | Urban | Surgery + Radiotherapy | Alive | 4 | high_burden |
KE-NRB-2018-00046 | 2,018 | 32 | 25-34 | Female | Breast | Adenocarcinoma | Poorly differentiated (Grade III) | Microscopy (histology/cytology) | Malignant | Urban | Surgery only | Alive | 38.1 | high_burden |
KE-NRB-2016-00047 | 2,016 | 49 | 45-54 | Female | Ovary | Other specified | Well differentiated (Grade I) | Microscopy (histology/cytology) | Malignant | Peri-urban | Chemo + Radiotherapy | Alive | 3.9 | high_burden |
KE-NRB-2009-00048 | 2,009 | 19 | 15-24 | Male | Prostate | Adenocarcinoma | Moderately differentiated (Grade II) | Microscopy (histology/cytology) | In situ | Urban | null | Dead | 11 | high_burden |
KE-NRB-2013-00049 | 2,013 | 63 | 55-64 | Female | Other | Squamous cell carcinoma | Moderately differentiated (Grade II) | Microscopy (histology/cytology) | In situ | Urban | null | Dead | 23.3 | high_burden |
KE-NRB-2018-00050 | 2,018 | 35 | 35-44 | Female | Breast | Adenocarcinoma | Poorly differentiated (Grade III) | Imaging + clinical | Malignant | Urban | Radiotherapy only | Alive | 12.4 | high_burden |
KE-NRB-2014-00051 | 2,014 | 66 | 65-74 | Male | Non-Hodgkin lymphoma | Adenocarcinoma | Undifferentiated (Grade IV) | Microscopy (histology/cytology) | Malignant | Urban | Surgery only | Dead | 1 | high_burden |
KE-NRB-2014-00052 | 2,014 | 44 | 35-44 | Female | Cervix uteri | Non-keratinizing carcinoma | Poorly differentiated (Grade III) | Microscopy (histology/cytology) | Malignant | Urban | Chemotherapy only | Dead | 11.3 | high_burden |
KE-NRB-2016-00053 | 2,016 | 78 | 75+ | Male | Other | Adenocarcinoma | Poorly differentiated (Grade III) | Microscopy (histology/cytology) | Malignant | Urban | Surgery + Chemotherapy | Dead | 1.7 | high_burden |
KE-NRB-2009-00054 | 2,009 | 60 | 55-64 | Male | Stomach | Non-keratinizing carcinoma | Unknown | Microscopy (histology/cytology) | Malignant | Urban | Chemo + Radiotherapy | Alive | 43.1 | high_burden |
KE-NRB-2018-00055 | 2,018 | 39 | 35-44 | Female | Thyroid | Non-keratinizing carcinoma | Well differentiated (Grade I) | Imaging + clinical | Malignant | Urban | Surgery only | Alive | 60 | high_burden |
KE-NRB-2010-00056 | 2,010 | 63 | 55-64 | Female | Breast | Squamous cell carcinoma | Poorly differentiated (Grade III) | Microscopy (histology/cytology) | Malignant | Urban | Surgery + Chemotherapy | Dead | 21.9 | high_burden |
KE-NRB-2009-00057 | 2,009 | 36 | 35-44 | Female | Cervix uteri | Other specified | Moderately differentiated (Grade II) | Microscopy (histology/cytology) | Malignant | Urban | Chemo + Radiotherapy | Alive | 60 | high_burden |
KE-NRB-2018-00058 | 2,018 | 36 | 35-44 | Female | Breast | Adenocarcinoma | Moderately differentiated (Grade II) | Microscopy (histology/cytology) | In situ | Urban | null | Dead | 9.2 | high_burden |
KE-NRB-2013-00059 | 2,013 | 33 | 25-34 | Male | Other | Leukemia | Poorly differentiated (Grade III) | Imaging + clinical | Malignant | Urban | Surgery only | Lost to follow-up | 5.7 | high_burden |
KE-NRB-2013-00060 | 2,013 | 50 | 45-54 | Male | Lung | Adenocarcinoma | Well differentiated (Grade I) | Microscopy (histology/cytology) | Benign/uncertain | Urban | null | Alive | 60 | high_burden |
KE-NRB-2018-00061 | 2,018 | 52 | 45-54 | Female | Breast | Squamous cell carcinoma | Moderately differentiated (Grade II) | Microscopy (histology/cytology) | Malignant | Peri-urban | Chemo + Radiotherapy | Alive | 60 | high_burden |
KE-NRB-2018-00062 | 2,018 | 28 | 25-34 | Female | Breast | Non-keratinizing carcinoma | Moderately differentiated (Grade II) | Microscopy (histology/cytology) | In situ | Urban | null | Lost to follow-up | 24.9 | high_burden |
KE-NRB-2018-00063 | 2,018 | 64 | 55-64 | Female | Other | Adenocarcinoma | Poorly differentiated (Grade III) | Microscopy (histology/cytology) | Malignant | Urban | Surgery + Radiotherapy | Alive | 16.4 | high_burden |
KE-NRB-2015-00064 | 2,015 | 52 | 45-54 | Male | Pancreas | Adenocarcinoma | Undifferentiated (Grade IV) | Imaging + clinical | Malignant | Urban | Chemo + Radiotherapy | Alive | 16.5 | high_burden |
KE-NRB-2013-00065 | 2,013 | 18 | 15-24 | Female | Cervix uteri | Adenocarcinoma | Moderately differentiated (Grade II) | Microscopy (histology/cytology) | Malignant | Urban | Chemo + Radiotherapy | Alive | 40 | high_burden |
KE-NRB-2016-00066 | 2,016 | 58 | 55-64 | Female | Cervix uteri | Adenocarcinoma | Undifferentiated (Grade IV) | Microscopy (histology/cytology) | Malignant | Urban | Surgery + Radiotherapy | Alive | 24.5 | high_burden |
KE-NRB-2015-00067 | 2,015 | 64 | 55-64 | Female | Breast | Other specified | Poorly differentiated (Grade III) | Microscopy (histology/cytology) | In situ | Urban | null | Alive | 58.1 | high_burden |
KE-NRB-2017-00068 | 2,017 | 34 | 25-34 | Female | Thyroid | Non-keratinizing carcinoma | Moderately differentiated (Grade II) | Microscopy (histology/cytology) | Malignant | Peri-urban | Radiotherapy only | Dead | 27.4 | high_burden |
KE-NRB-2017-00069 | 2,017 | 92 | 75+ | Male | Prostate | Non-keratinizing carcinoma | Moderately differentiated (Grade II) | Microscopy (histology/cytology) | Malignant | Urban | Radiotherapy only | Lost to follow-up | 60 | high_burden |
KE-NRB-2014-00070 | 2,014 | 78 | 75+ | Female | Other | Squamous cell carcinoma | Poorly differentiated (Grade III) | Microscopy (histology/cytology) | Malignant | Peri-urban | Surgery only | Alive | 7 | high_burden |
KE-NRB-2016-00071 | 2,016 | 20 | 15-24 | Male | Leukemia | Squamous cell carcinoma | Well differentiated (Grade I) | Microscopy (histology/cytology) | Malignant | Urban | Chemotherapy only | Alive | 5.1 | high_burden |
KE-NRB-2014-00072 | 2,014 | 81 | 75+ | Female | Ovary | Non-keratinizing carcinoma | Poorly differentiated (Grade III) | Microscopy (histology/cytology) | Malignant | Urban | Chemotherapy only | Alive | 36.5 | high_burden |
KE-NRB-2014-00073 | 2,014 | 77 | 75+ | Female | Cervix uteri | Leukemia | Unknown | Microscopy (histology/cytology) | Malignant | Urban | Chemotherapy only | Alive | 58.4 | high_burden |
KE-NRB-2016-00074 | 2,016 | 60 | 55-64 | Female | Breast | Squamous cell carcinoma | Moderately differentiated (Grade II) | Clinical only | Malignant | Urban | Surgery + Radiotherapy | Alive | 60 | high_burden |
KE-NRB-2012-00075 | 2,012 | 87 | 75+ | Female | Cervix uteri | Adenocarcinoma | Well differentiated (Grade I) | Microscopy (histology/cytology) | Malignant | Urban | Chemotherapy only | Alive | 27.3 | high_burden |
KE-NRB-2013-00076 | 2,013 | 56 | 55-64 | Female | Breast | Adenocarcinoma | Moderately differentiated (Grade II) | Microscopy (histology/cytology) | Malignant | Peri-urban | Chemotherapy only | Dead | 1.8 | high_burden |
KE-NRB-2010-00077 | 2,010 | 52 | 45-54 | Female | Breast | Adenocarcinoma | Poorly differentiated (Grade III) | Microscopy (histology/cytology) | Malignant | Urban | Surgery only | Dead | 22.3 | high_burden |
KE-NRB-2015-00078 | 2,015 | 45 | 45-54 | Female | Cervix uteri | Squamous cell carcinoma | Undifferentiated (Grade IV) | Death certificate only | Malignant | Urban | Surgery + Chemotherapy | Dead | 11.1 | high_burden |
KE-NRB-2012-00079 | 2,012 | 54 | 45-54 | Female | Cervix uteri | Non-keratinizing carcinoma | Poorly differentiated (Grade III) | Microscopy (histology/cytology) | Malignant | Peri-urban | Surgery + Chemotherapy | Alive | 60 | high_burden |
KE-NRB-2013-00080 | 2,013 | 16 | 15-24 | Female | Other | Squamous cell carcinoma | Poorly differentiated (Grade III) | Microscopy (histology/cytology) | Malignant | Urban | Surgery only | Alive | 10.6 | high_burden |
KE-NRB-2009-00081 | 2,009 | 64 | 55-64 | Male | Colorectum | Adenocarcinoma | Undifferentiated (Grade IV) | Microscopy (histology/cytology) | Malignant | Urban | Surgery + Radiotherapy | Alive | 23 | high_burden |
KE-NRB-2010-00082 | 2,010 | 61 | 55-64 | Female | Other | Non-keratinizing carcinoma | Well differentiated (Grade I) | Clinical only | Malignant | Rural | Chemo + Radiotherapy | Alive | 60 | high_burden |
KE-NRB-2009-00083 | 2,009 | 55 | 55-64 | Male | Colorectum | Sarcoma | Moderately differentiated (Grade II) | Clinical only | Malignant | Urban | Surgery only | Dead | 15.9 | high_burden |
KE-NRB-2017-00084 | 2,017 | 43 | 35-44 | Female | Other | Adenocarcinoma | Poorly differentiated (Grade III) | Imaging + clinical | Malignant | Urban | Surgery + Chemotherapy | Alive | 36.5 | high_burden |
KE-NRB-2013-00085 | 2,013 | 86 | 75+ | Male | Colorectum | Leukemia | Poorly differentiated (Grade III) | Microscopy (histology/cytology) | Malignant | Urban | Surgery + Radiotherapy | Dead | 19.3 | high_burden |
KE-NRB-2015-00086 | 2,015 | 12 | 0-14 | Male | Colorectum | Adenocarcinoma | Moderately differentiated (Grade II) | Microscopy (histology/cytology) | Malignant | Urban | Chemotherapy only | Alive | 1.2 | high_burden |
KE-NRB-2016-00087 | 2,016 | 44 | 35-44 | Male | Other | Adenocarcinoma | Moderately differentiated (Grade II) | Microscopy (histology/cytology) | Malignant | Peri-urban | Chemotherapy only | Alive | 55.9 | high_burden |
KE-NRB-2016-00088 | 2,016 | 58 | 55-64 | Male | Other | Adenocarcinoma | Well differentiated (Grade I) | Microscopy (histology/cytology) | Malignant | Peri-urban | Surgery + Chemotherapy | Alive | 11.2 | high_burden |
KE-NRB-2017-00089 | 2,017 | 63 | 55-64 | Female | Corpus uteri | Lymphoma | Undifferentiated (Grade IV) | Imaging + clinical | Malignant | Urban | No treatment | Lost to follow-up | 60 | high_burden |
KE-NRB-2013-00090 | 2,013 | 36 | 35-44 | Female | Other | Squamous cell carcinoma | Well differentiated (Grade I) | Microscopy (histology/cytology) | Malignant | Peri-urban | Radiotherapy only | Alive | 60 | high_burden |
KE-NRB-2012-00091 | 2,012 | 40 | 35-44 | Female | Other | Adenocarcinoma | Unknown | Other | Malignant | Urban | Radiotherapy only | Alive | 60 | high_burden |
KE-NRB-2011-00092 | 2,011 | 31 | 25-34 | Female | Cervix uteri | Sarcoma | Moderately differentiated (Grade II) | Microscopy (histology/cytology) | Malignant | Urban | Surgery + Chemotherapy | Alive | 38.1 | high_burden |
KE-NRB-2018-00093 | 2,018 | 60 | 55-64 | Male | Prostate | Squamous cell carcinoma | Unknown | Microscopy (histology/cytology) | Malignant | Peri-urban | Chemotherapy only | Dead | 6.5 | high_burden |
KE-NRB-2014-00094 | 2,014 | 41 | 35-44 | Female | Other | Adenocarcinoma | Poorly differentiated (Grade III) | Microscopy (histology/cytology) | Malignant | Urban | Surgery + Chemotherapy | Alive | 0.1 | high_burden |
KE-NRB-2010-00095 | 2,010 | 52 | 45-54 | Male | Non-Hodgkin lymphoma | Squamous cell carcinoma | Poorly differentiated (Grade III) | Imaging + clinical | Malignant | Urban | Surgery only | Alive | 60 | high_burden |
KE-NRB-2016-00096 | 2,016 | 26 | 25-34 | Female | Cervix uteri | Non-keratinizing carcinoma | Poorly differentiated (Grade III) | Microscopy (histology/cytology) | Malignant | Urban | Surgery only | Alive | 60 | high_burden |
KE-NRB-2015-00097 | 2,015 | 67 | 65-74 | Male | Leukemia | Squamous cell carcinoma | Poorly differentiated (Grade III) | Microscopy (histology/cytology) | Malignant | Urban | Surgery + Radiotherapy | Alive | 60 | high_burden |
KE-NRB-2010-00098 | 2,010 | 74 | 65-74 | Female | Other | Squamous cell carcinoma | Poorly differentiated (Grade III) | Death certificate only | In situ | Peri-urban | null | Dead | 39.3 | high_burden |
KE-NRB-2015-00099 | 2,015 | 61 | 55-64 | Female | Other | Adenocarcinoma | Unknown | Clinical only | Malignant | Urban | Chemotherapy only | Alive | 25.5 | high_burden |
KE-NRB-2014-00100 | 2,014 | 63 | 55-64 | Female | Other | Adenocarcinoma | Well differentiated (Grade I) | Microscopy (histology/cytology) | Malignant | Urban | Surgery + Chemotherapy | Dead | 60 | high_burden |
Kenya Cancer Registry - Nairobi | Africa (Electric Sheep Africa metadata inventory)
Size category: 10K<n<100K - Formats: csv - Sector: health - Engineered by Electric Sheep Africa
TL;DR
This dataset is part of the Electric Sheep Africa catalog on Hugging Face. It is indexed for African data discovery with standardized metadata, loading guidance, provenance notes, and analyst-oriented context.
What This Dataset Covers
Health datasets help researchers examine disease burden, service delivery, risk factors, outcomes, and public-health program performance.
Dataset context from the existing Hugging Face card: ⚠️ Synthetic dataset — Parameterized from published SSA literature, not real observations. Not suitable for empirical analysis or policy inference. Kenya Cancer Registry - Nairobi Abstract This synthetic dataset represents population-based cancer registry data for nairobi county and is designed to address the significant data gap in cancer research for sub-Saharan Africa. The dataset contains 4,000-6,000 per scenario records per scenario with key epidemiological… See the full description on the dataset page: https://huggingface.co/datasets/electricsheepafrica/africa-synth-cancer-kenya-cancer-nairobi-kenya.
Dataset Profile
| Field | Value |
|---|---|
| Hugging Face repo | electricsheepafrica/africa-synth-cancer-kenya-cancer-nairobi-kenya |
| Sector | health |
| Topic tags | cancer, oncology, synthetic, healthcare, sub-saharan-africa, kenya |
| Modalities | tabular, text |
| Formats | csv |
| Size category | 10K<n<100K |
| Countries | Kenya |
| ISO3 coverage | KEN |
| Last modified on HF | 2026-04-14 22:47:28+00:00 |
| Inventory snapshot | 2026-07-16T16:00:34Z |
How To Read This Dataset
- Start from the repository files and the dataset viewer when available.
- Treat the README context as a fast orientation layer; confirm variable definitions and units in the data files before modeling.
- Use explicit country columns when present. When geography is only implied by the title or source metadata, document that assumption in downstream analysis.
- Preserve missing values until you have a defensible imputation rule.
Usage
from datasets import load_dataset
ds = load_dataset("electricsheepafrica/africa-synth-cancer-kenya-cancer-nairobi-kenya")
print(ds)
split_name = next(iter(ds))
table = ds[split_name]
print(table.features)
print(table[:3])
Convert To Pandas When Tabular
from datasets import Dataset
first_split = ds[next(iter(ds))]
if isinstance(first_split, Dataset):
df = first_split.to_pandas()
print(df.head())
Data Quality Notes
- This card was standardized from the Electric Sheep Africa Hugging Face metadata inventory.
- Exact schema, row counts, and source files should be inspected in the repository data files.
- Metadata gaps from the inventory: upstream_publisher.
- Do not infer policy meaning from labels alone; confirm definitions, units, and methods in the source material.
Source And Provenance
- Source context: Electric Sheep Africa metadata inventory
- Publisher/source attribution: Public dataset metadata
- License: CC BY 4.0
- Hugging Face URL: https://huggingface.co/datasets/electricsheepafrica/africa-synth-cancer-kenya-cancer-nairobi-kenya
- Inventory retrieved at:
2026-07-16T16:00:34Z
Suggested Analyses
- Inspect schema and missingness before modeling.
- Profile variables by geography, time, and subgroup columns where present.
- Join with other Electric Sheep Africa datasets using explicit country, year, and indicator fields when available.
- Build reproducible notebooks that cite both the original source context and the Electric Sheep Africa Hugging Face repo.
Citation
@misc{electric_sheep_africa_africa_synth_cancer_kenya_cancer_nairobi_kenya_2026,
title = {Kenya Cancer Registry - Nairobi | Africa (Electric Sheep Africa metadata inventory)},
author = {Public dataset metadata},
year = {2026},
url = {https://huggingface.co/datasets/electricsheepafrica/africa-synth-cancer-kenya-cancer-nairobi-kenya},
publisher = {Hugging Face Datasets, engineered by Electric Sheep Africa},
howpublished = {\url{https://huggingface.co/datasets/electricsheepafrica/africa-synth-cancer-kenya-cancer-nairobi-kenya}}
}
License
Released under CC BY 4.0.
Original source rights remain with the original publisher or data provider. Electric Sheep Africa engineering standardizes discovery metadata, documentation, and usage guidance for analysis on Hugging Face.
About Electric Sheep Africa
Electric Sheep Africa publishes ML-ready African public datasets on Hugging Face.
Provenance: metadata-backed README standardized 2026-08-12 by the Electric Sheep Africa README system. Inventory source: catalog/esa_metadata_inventory/master_metadata.jsonl.
- Downloads last month
- 40